AngioDynamics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

AngioDynamics Stock Summary

AngioDynamics competes with AptarGroup, Repro Med, AtriCure, Akoya Biosciences, and ICU Medical. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people.

AngioDynamics Key Financial Ratios

AngioDynamics Key Balance Sheet Accounts

AngioDynamics Key Income Statement Accounts

AngioDynamics Key Cash Accounts

AngioDynamics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AngioDynamics competition to find correlations between indicators driving AngioDynamics's intrinsic value. More Info.AngioDynamics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, AngioDynamics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.

AngioDynamics' Earnings Breakdown by Geography

AngioDynamics Systematic Risk

Today, most investors in AngioDynamics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AngioDynamics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of AngioDynamics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of AngioDynamics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AngioDynamics. We use our internally-developed statistical techniques to arrive at the intrinsic value of AngioDynamics based on widely used predictive technical indicators. In general, we focus on analyzing AngioDynamics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AngioDynamics's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.